文献速递脊柱关节炎

哥伦比亚HLA-B27+或HLA-B15+脊柱关节炎患者ERAP2基因多态性关联及与临床表型的关系

Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance.
PubMed 文献 · RMD Open · 2020-01-01

研究纳入104例符合ASAS标准的脊柱关节炎患者,其中HLA-B27+者70例、HLA-B15+者34例,检测ERAP1和ERAP2多个SNP。发现ERAP2 SNPs单倍型TGT在HLA-B15+患者中更常见,而TGC和CAT在HLA-B27+患者中更常见,这些关联可能与中轴或外周关节受累为主有关。

要点

  • ERAP2单倍型TGT与HLA-B15+脊柱关节炎相关(OR 2.943,95%CI 1.264-6.585,P=0.009)。
  • ERAP2单倍型TGC和CAT与HLA-B27+脊柱关节炎相关(OR分别为4.483和9.014)。
  • ERAP1多态性及单倍型频率在HLA-B15+与HLA-B27+患者间无差异。

核心结论

  • HLA-B15+脊柱关节炎患者与ERAP2 SNPs单倍型TGT相关,HLA-B27+患者与ERAP2单倍型TGC和CAT相关。
  • 这些关联可能与疾病临床表现(外周或中轴为主)相关。

研究设计与样本

  • 纳入104例符合ASAS标准的脊柱关节炎患者,HLA分型用PCR法,ERAP1和ERAP2 SNPs用实时PCR法检测。

主要发现

  • 104例患者中70例为HLA-B27+,34例为HLA-B15+。
  • ERAP1和ERAP2各SNP在HLA-B15+与HLA-B27+患者间的分布无差异。
  • ERAP1 SNP单倍型及HLA-B15或HLA-B27等位基因频率无差异。
  • ERAP2 SNPs rs2549782/rs2248374/rs2910686组成的单倍型TGT在HLA-B15+患者中更常见(OR 2.943,95%CI 1.264-6.585;P=0.009)。
  • ERAP2单倍型TGC与HLA-B27+患者相关(OR 4.483,95%CI 1.524-13.187;p=0.003),CAT也与HLA-B27+相关(OR 9.014,95%CI 1.181-68.807;p=0.009)。

临床怎么用

  • 在脊柱关节炎患者中检测HLA-B27/HLA-B15及ERAP2单倍型可能有助于提示中轴或外周为主的临床表型。

局限性

  • 样本量有限(104例),HLA-B15+亚组仅34例,关联结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the association between endoplasmic reticulum aminopeptidase (ERAP)1 and ERAP2 single-nucleotide polymorphisms (SNPs) and human leukocyte antigens (HLA)-B27+ or HLA-B15+ patients with spondyloarthritis (SpA). METHODS: 104 patients with SpA according to Assessment of Spondyloarthritis International Society criteria were included in the study. HLA typing was performed by PCR. The polymorphisms were determined by real-time PCR on genomic DNA using customised probes for SNPs rs27044, rs17482078, rs10050860 and rs30187 in ERAP1, and rs2910686, rs2248374 and rs2549782 in ERAP2. RESULTS: 70 of the104 patients with SpA were HLA-B27+ and 34 were HLA-B15+. The distribution of ERAP1 and ERAP2 SNPs between the HLA-B15+ and HLA-B27+ patients with SpA did not reveal differences. Likewise, no differences in the frequencies of ERAP1 SNP haplotypes and alleles HLA-B15 or HLA-B27 were found. Interestingly, however, the frequencies of three particular haplotypes formed by ERAP2 SNPs rs2549782/rs2248374/rs2910686 varied between HLA-B15+ and HLA-B27+ patients: the ERAP2 SNPs haplotype TGT was more common in HLA-B15+ patients with SpA (OR 2.943, 95% CI 1.264 to 6.585; P=0.009), whereas the ERAP2 SNP haplotypes TGC and CAT were more associated with HLA-B27+ patients with SpA: (OR 4.483, 95% CI 1.524 to 13.187; p=0.003) and (OR 9.014, 95% CI 1.181 to 68.807; p=0.009), respectively. CONCLUSION: An association was found between HLA-B15+ patients with SpA and haplotype TGT of ERAP2 SNPs. On the other hand, HLA-B27+ patients with SpA were associated with ERAP2 haplotypes TGC and CAT. These associations could be related to the clinical presentation of the disease, specifically with a peripheral or axial predominance, respectively.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Londono J, Santos AM, Rueda JC, et al. Association of ERAP2 polymorphisms in Colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation: axial or peripheral predominance. RMD Open. 2020. PMID: 32917832. doi:10.1136/rmdopen-2020-001250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。